First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial

Ki Hyeong Lee, Kazuhiko Nakagawa, Shunichi Sugawara et al.|Lung Cancer|2025

Cited by 9